Silymarin prevents lipid accumulation in the liver of rats with type 2 diabetes via sirtuin1 and SREBP-1c

Journal of Basic and Clinical Physiology and Pharmacology
Nejat KheiripourMohammad Hashemnia

Abstract

In this study, we have investigated whether silymarin intake influences lipid and glycogen content in conjunction with sirtuin1 (SIRT1) and sterol regulatory element-binding protein 1c (SREBP-1c) expressions in liver of type 2 diabetic rat. Thirty-six male Wistar rats were randomly divided into six groups: control groups (C) and diabetic groups (D); the control groups received 60 or 120 mg/kg silymarin (C+S60 or C+S120), and the diabetic groups received 60 or 120 mg/kg silymarin (D+S60 or D+S120) daily for 8 weeks. Serum biochemical parameters, as well as glycogen, lipid and oxidative stress biomarkers, in the liver tissue were measured by spectrophotometric methods. Additionally, SIRT1 and SREBP-1c messenger RNA (mRNA) expressions were evaluated by quantitative polymerase chain reaction. Diabetes caused a significantly increased fasting blood sugar, homeostasis model assessment for insulin resistance, liver total cholesterol and triglyceride (TG) content, which were attenuated after the administration of silymarin. Dietary silymarin caused the improvement of lipid content in the liver of diabetic rats. Moreover, silymarin administration promoted SIRT1, suppressed SREBP-1c mRNA expression, reduced liver nitric oxide and protein...Continue Reading

References

Oct 1, 1988·Analytical Biochemistry·L H Johansson, L A Borg
Jan 1, 1995·Rapid Communications in Mass Spectrometry : RCM·P R TillerC D Bevan
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Apr 1, 1963·Proceedings of the Society for Experimental Biology and Medicine·D E KIZER, B A HOWELL
Mar 26, 2004·Reviews in Endocrine & Metabolic Disorders·Martin Krssak, Michael Roden
Jul 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Paul T PflugerMatthias H Tschöp
Aug 30, 2008·Biochemical and Biophysical Research Communications·Mika SekiyaKazuichi Sakamoto
Sep 8, 2010·The Journal of Biological Chemistry·Bhaskar PonugotiJongsook Kim Kemper
Oct 26, 2010·Methods in Molecular Biology·Mohamed Slaoui, Laurence Fiette
Mar 26, 2011·Experimental Diabetes Research·Fábio Cangeri Di NasoNorma Anair Possa Marroni
Apr 7, 2011·Current Pharmaceutical Biotechnology·János Féher, Gabriella Lengyel
Dec 17, 2011·Journal of Hepatology·Lars P BechmannAli Canbay
May 15, 2013·Journal of Diabetes Research·Lulu WangNingning Dang
Mar 29, 2014·World Journal of Hepatology·Nancy Vargas-MendozaJosé A Morales-González
Sep 23, 2014·Metabolism: Clinical and Experimental·Liya Wu, Klaus G Parhofer
Jun 28, 2015·Biochemical and Biophysical Research Communications·Jaeyong LeeJunichi Fujii
Jul 17, 2015·BMC Complementary and Alternative Medicine·Omolola R OyenihiOluwafemi O Oguntibeju
Nov 14, 2015·Diabetes & Metabolism Journal·Klaus G Parhofer
Jan 26, 2017·Journal of Basic and Clinical Physiology and Pharmacology·Omar FaridMohamed Eddouks
May 31, 2017·Immunopharmacology and Immunotoxicology·Majid BahabadiIraj Khodadadi
Jul 25, 2017·Biological Trace Element Research·Naser ZanganehMohammad Yousef Alikhani

❮ Previous
Next ❯

Citations

Jul 7, 2018·Archives of Pharmacal Research·Chun ChuFanxing Xu
Feb 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·María Del Carmen Villegas-AguilarAntonio Segura-Carretero
Aug 10, 2019·Clinical and Experimental Pharmacology & Physiology·Adel MohammadalipourAlireza Pouyandeh Ravan
Aug 5, 2020·Life Sciences·Ahmed M SayedAyman M Mahmoud
Feb 11, 2019·Life Sciences·Hossein ShateriHeresh Moridi
Sep 17, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Aline Maria StolfAlexandra Acco

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
light microscopy
PCR
PCR and

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.